[1] COE F L, EVAN A, WORCESTER E.Kidney stone disease[J].J Clin Invest, 2005, 115(10):2598-2608.
[2] KIRKALI Z, RASOOLY R, STAR R A, et al.Urinary Stone Disease:progress, status, and needs[J].Urology, 2015, 86(4):651-653.
[3] FRICK K K, KRIEGER N S, BUSHINSKY D A.Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat[J].Curr Opin Nephrol Hypertens, 2015, 24(4):336-344
[4] 刘文刚, 张光远, 黎明, 等.CXCL1/2/10介导的免疫炎症与草酸钙结石形成的关系[J].东南大学学报(医学版), 2022, 41(3):402-407.
[5] STADTMANN A, ZARBOCK A.CXCR2:From bench to bedside[J].Front Immunol, 2012, 3:263.
[6] SALIMINEJAD K, KHORRAM KHORSHID H R, SOLEYMANI F S, et al.An overview of microRNAs:biology, functions, therapeutics, and analysis methods[J].J Cell Physiol, 2019, 234(5):5451-5465.
[7] 张元忠, 陈桂芝, 陈刚.土家族药茅岩莓的生药学研究[J].中国民族医药杂志, 2004, 10(2):17-18.
[8] ZENG X, XI Y, JIANG W.Protective roles of flavonoids and flavonoid-rich plant extracts against urolithiasis:a review[J].Crit Rev Food Sci Nutr, 2019, 59(13):2125-2135.
[9] TANG G H, LIU J H, SUN X Y, et al.Carboxymethylation of desmodium styracifolium polysaccharide and its repair effect on damaged HK-2 cells[J].Oxid Med Cell Longev, 2022, 2022:2082263.
[10] LAI Y, LIANG X, ZHONG F, et al.Allicin attenuates calcium oxalate crystal deposition in the rat kidney by regulating gap junction function[J].J Cell Physiol, 2019, 234(6):9640-9651.
[11] 曾国华, 麦赞林, 夏术阶, 等.中国成年人群尿石症患病率横断面调查[J].中华泌尿外科杂志, 2015, 36(7):528-532.
[12] WU W, YANG D, TISELIUS H G.The Characteristics of the stone and urine composition in Chinese stone formers:primary report of a single-center results[J].Urology, 2014, 83:732-737.
[13] KHAN S R, CANALES B K, DOMINGUEZ-GUTIERREZ P R.Randall's plaque and calcium oxalate stone formation:role for immunity and inflammation[J].Nat Rev Nephrol, 2021, 17(6):417-433.
[14] OLSON T S, LEY K.Chemokines and chemokine receptors in leukocyte trafficking[J].Am J Physiol Regul Integr Comp Physiol, 2002, 283(1):R7-R28.
[15] COE F L, WORCESTER E M, EVAN A P.Idiopathic hypercalciuria and formation of calcium renal stones[J].Nat Rev Nephrol, 2016, 12(9):519-533.
[16] TAGUCHI K, OKADA A, HAMAMOTO S, et al.M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development[J].Sci Rep, 2016, 6:35167.
[17] ZHANG H, SUN X Y, CHEN X W, et al.Degraded porphyrayezoensis polysaccharide protects HK-2 cells and reduces nano-COM crystal toxicity, adhesion and endocytosis[J].J Mater Chem B, 2020, 8(32):7233-7252. |